Deep Dive Ticker Tape
Article published Mar 10, 2026. Prices below use latest available snapshots.
ISRG Price Structure
Loading chart…
Loading timeframes…
Conviction: Medium (tempered by 5+ weeks of stale data) Status: Data stale — RSI 8.8 (as of Feb 5), price $476.32 per last data. Actual current price unknown.
Data note: OHLC data last updated 2026-02-05.
Quick Snapshot
| Signal | Reading |
|---|---|
| Overall | 🟢 RSI 8.8 (stale — Feb 5, 2026) — most extreme reading in our universe if still valid. Price $476.32 per stale data. Data now 5+ weeks old. |
| Moat | Wide (surgical robotics monopoly — da Vinci system) |
| Key insight | ISRG OHLC data has been stale since Feb 5, 2026 — now over 5 weeks without an update. This is the most critical data quality issue in our coverage. RSI 8.8 sustained for 5+ weeks is historically impossible — the data is simply not refreshing. Da Vinci monopoly thesis unquestionably intact. MUST fetch fresh data before any action. |
Action Matrix
| Action | Level | Why |
|---|---|---|
| Current | ⏳ Wait for fresh data | Cannot act without current price. Data 5+ weeks stale. |
| If fresh RSI still < 15 | ✅ Buy (small) | RSI extreme + monopoly moat = strong signal |
| If fresh RSI 15-30 | 📈 Accumulate | Still oversold; reduced urgency |
| If fresh RSI > 30 | 🔍 Watch | Recovery may be underway |
| Entry Zone (if still oversold) | $455 - $490 | Based on stale data |
| Stop-Loss | $405 (-15%) | Below key support |
| Target | $600 (+26%) | Recovery toward recent levels |
Extended analysis
Price Data
| Stock | Price | 1D | 7D | 30D | 3M | 52wkHi | RSI | Status | Action |
|---|---|---|---|---|---|---|---|---|---|
| ISRG | $476.32* | -0.5%* | -6.2%* | -19.7%* | — | -21.1%* | 8↓* | 🟢 Extreme Oversold* | ⏳ Fetch Data |
All values from stale OHLC data (last entry: Feb 5, 2026). Treat as outdated.
Company Overview
One-Liner
Intuitive Surgical manufactures the da Vinci robotic surgical system, with a near-monopoly in soft-tissue robotic surgery globally.
Business Model
| Question | Answer |
|---|---|
| What they sell | da Vinci surgical systems (hardware), instruments/accessories (per-procedure), service contracts |
| Who pays | Hospitals, surgical centers globally |
| Revenue model | System placements (upfront or lease), instrument consumables (per procedure), annual service contracts |
| How sticky | Extremely high — hospitals train entire surgical staff, $2M+ investment, 10+ year life |
Key Segments
| Segment | Revenue % | Growth | Notes |
|---|---|---|---|
| Instruments & Accessories | ~60% | +18% YoY | Highest-margin, recurring |
| Systems | ~25% | +12% YoY | New da Vinci 5 placements |
| Services | ~15% | +10% YoY | Annual maintenance contracts |
Competitive Analysis
Competitive Moat
| Moat Type | Present? | Evidence |
|---|---|---|
| Switching costs | 🟢 | Surgeon training 12-18 months, hospital capital commitment |
| Intangible assets | 🟢 | 10,000+ patents, FDA approvals, 30+ years surgical data |
| Network effects | 🟢 | More procedures = more outcome data = more placements |
| Efficient scale | 🟢 | 10,000+ installed systems globally |
Moat Width: Wide Moat Trend: Widening — da Vinci 5 driving upgrade cycle
Bull Case
- da Vinci monopoly — 10,000+ installed systems. No serious competitor for 5+ years.
- Recurring consumable flywheel — Each system generates $500K-$1M+ annually.
- da Vinci 5 upgrade cycle — New generation driving replacements.
- Procedure growth — Robotic procedures growing 15%+ annually.
- RSI 8.8 = historical extreme — If valid, exceptional entry opportunity.
Bear Case
- Insider selling persists — $282.6M net selling.
- Procedure volume risk — Hospital capex constraints.
- da Vinci 5 adoption slower than expected.
- Regulatory issues — FDA scrutiny on outcomes.
Thesis Killers
- Procedure growth drops below 8% for 2 quarters
- Major hospital system cancels for competitor
- Medtronic Hugo achieves broad FDA approval
Research Log
| Date | Update |
|---|---|
| 2026-02-16 | Created deep dive. RSI 8.8 extreme. $476.32. Insider selling -$282.6M. Action: Buy (with caution). |
| 2026-02-22 | Data stale. Price/RSI unchanged. |
| 2026-02-26 | Data stale. 3+ weeks without update. |
| 2026-03-03 | Data stale. 4 weeks without update. |
| 2026-03-10 | Data still stale (Feb 5, 2026) — now 5+ weeks. |
The Gold
Key Discoveries
| Discovery | Implication |
|---|---|
| RSI 8.8 — data 5+ weeks stale | Data quality failure; real RSI unknown |
| da Vinci 5 upgrade cycle underway | Fundamentals excellent regardless of price |
| Insider selling $282.6M | Management reducing exposure |
Open Questions
- CRITICAL: What is the actual current price and RSI?
- Has ISRG bounced from $476.32 since Feb 5?
- Are insider sales on a 10b5-1 schedule?
- What is da Vinci 5 placement pace?
Mistakes (Don't Repeat)
| Mistake | Lesson |
|---|---|
| Not fetching fresh OHLC data over 5 updates | Refresh price data every time before updating |
Sources
- Fundamentals figures: company-reported results (quarterly/annual filings) as available at the artifact date; predates the desk's EDGAR reconciliation gate — figures not re-verified after publication.